Price$0.42+0.02 (+5.47%)
04:45 PM07:30 PM
News · 26 weeks15-78%
2026-02-012026-07-26
Mix1190d
- Insider7(64%)
- Other2(18%)
- SEC Filings2(18%)
Latest news
25 items- SECSEC Form 6-K filed by Cellyan Biotechnology Co. Ltd6-K - Cellyan Biotechnology Co., Ltd (0002007702) (Filer)
- PRCellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Additional Compliance Grace PeriodHONG KONG, July 16, 2026 (GLOBE NEWSWIRE) -- Cellyan Biotechnology Co., Ltd (NASDAQ:HKPD) (the "Company"), a leading provider of over the counter ("OTC") pharmaceutical cross-border e-commerce supply chain services in Hong Kong, today announced that it received a notification letter (the "Notification Letter") on July 14, 2026 from Nasdaq's Listing Qualifications Department indicating that the Company has been granted an additional 180 calendar day period, or until January 11, 2027, to regain compliance with the Nasdaq’s minimum $1.00 closing bid price requirement ("the Minimum Bid Price Requirement") as set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on Nasdaq. To rega
- SECSEC Form EFFECT filed by Cellyan Biotechnology Co. LtdEFFECT - Cellyan Biotechnology Co., Ltd (0002007702) (Filer)
- SECSEC Form F-3 filed by Cellyan Biotechnology Co. LtdF-3 - Cellyan Biotechnology Co., Ltd (0002007702) (Filer)
- INSIDERSEC Form 3 filed by new insider Chan Kam Leung3 - Cellyan Biotechnology Co., Ltd (0002007702) (Issuer)
- INSIDERNew insider Wong Lap Sun claimed ownership of 18,468 units of Class A Ordinary Shares (SEC Form 3)3 - Cellyan Biotechnology Co., Ltd (0002007702) (Issuer)
- INSIDERSEC Form 3 filed by new insider Wang Zifeng3 - Cellyan Biotechnology Co., Ltd (0002007702) (Issuer)
- INSIDERSEC Form 3 filed by new insider Liu Shu3 - Cellyan Biotechnology Co., Ltd (0002007702) (Issuer)
- INSIDERSEC Form 3 filed by new insider Zhou Mike Yao3 - Cellyan Biotechnology Co., Ltd (0002007702) (Issuer)
- INSIDERSEC Form 3 filed by new insider Wu Jingyan3 - Cellyan Biotechnology Co., Ltd (0002007702) (Issuer)
- INSIDERSEC Form 3 filed by new insider Liang Chenyu Andy3 - Cellyan Biotechnology Co., Ltd (0002007702) (Issuer)
- SECSEC Form EFFECT filed by Cellyan Biotechnology Co. LtdEFFECT - Cellyan Biotechnology Co., Ltd (0002007702) (Filer)
- SECSEC Form F-1 filed by Cellyan Biotechnology Co. LtdF-1 - Cellyan Biotechnology Co., Ltd (0002007702) (Filer)
- SECSEC Form 6-K filed by Cellyan Biotechnology Co. Ltd6-K - Cellyan Biotechnology Co., Ltd (0002007702) (Filer)
- SECSEC Form 6-K filed by Cellyan Biotechnology Co. Ltd6-K - Cellyan Biotechnology Co., Ltd (0002007702) (Filer)
- SECSEC Form 6-K filed by Cellyan Biotechnology Co. Ltd6-K - Cellyan Biotechnology Co., Ltd (0002007702) (Filer)
- PRCellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price DeficiencyHONG KONG, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Cellyan Biotechnology Co., Ltd (NASDAQ:HKPD) (the "Company"), a leading provider of over the counter ("OTC") pharmaceutical cross-border e-commerce supply chain services in Hong Kong, today announced that it received a notification letter (the "Notification Letter") dated January 12, 2026 from Nasdaq's Listing Qualifications Department indicating that the closing bid price of the Company's class A ordinary shares of par value of US$0.001 each was below the minimum requirement of US$1.00 per share for 30 consecutive business days from November 26, 2025 through January 9, 2026, and the Company was therefore currently not in compliance with the min
- SECSEC Form 6-K filed by Hong Kong Pharma Digital Technology Holdings Limited6-K - Cellyan Biotechnology Co., Ltd (0002007702) (Filer)
- SECSEC Form 6-K filed by Hong Kong Pharma Digital Technology Holdings Limited6-K - Hong Kong Pharma Digital Technology Holdings Ltd (0002007702) (Filer)
- PRHong Kong Pharma Digital Announced Results of 2025 Annual Meeting of StockholdersHONG KONG, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ:HKPD) ("HKPD" or the "Company"), a leading provider of over the counter ("OTC") pharmaceutical cross-border e-commerce supply chain services in Hong Kong, today announced that all proposals at the Company's 2025 annual meeting of stockholders held on December 12, 2025 local time were duly passed. The shareholders of the Company passed and approved the following proposals: Proposal No. 1: The re-election of five directors, Chenyu Liang, Lap Sun Wong, Mike Yao Zhou, Jingyan Wu, Dr. Kam Leung Chan, each to serve until the 2026 Annual Meeting of Stockholders; Proposal No. 2: The ratific
- SECSEC Form 6-K filed by Hong Kong Pharma Digital Technology Holdings Limited6-K - Hong Kong Pharma Digital Technology Holdings Ltd (0002007702) (Filer)
- SECSEC Form 6-K filed by Hong Kong Pharma Digital Technology Holdings Limited6-K - Hong Kong Pharma Digital Technology Holdings Ltd (0002007702) (Filer)
- SECSEC Form 6-K filed by Hong Kong Pharma Digital Technology Holdings Limited6-K - Hong Kong Pharma Digital Technology Holdings Ltd (0002007702) (Filer)
- SECSEC Form 6-K filed by Hong Kong Pharma Digital Technology Holdings Limited6-K - Hong Kong Pharma Digital Technology Holdings Ltd (0002007702) (Filer)
- SECSEC Form 20-F filed by Hong Kong Pharma Digital Technology Holdings Limited20-F - Hong Kong Pharma Digital Technology Holdings Ltd (0002007702) (Filer)
HKPD FAQ
5 questionsWhere does HKPD stock trade?
Cellyan Biotechnology Co. Ltd (HKPD) is listed on NASDAQ.What sector and industry is HKPD in?
Cellyan Biotechnology Co. Ltd operates in the Health Care sector, Other Pharmaceuticals industry.When did Cellyan Biotechnology Co. Ltd go public?
Cellyan Biotechnology Co. Ltd (HKPD) completed its IPO in 2025.What companies are similar to HKPD?
Notable peers in the same industry include MCK (McKesson Corporation), COR (Cencora Inc.), CAH (Cardinal Health Inc.), ABC (AmerisourceBergen Corporation), CVET (Covetrus Inc.). Compare HKPD side-by-side with any of them on Quantisnow.How can I track HKPD on Quantisnow?
Quantisnow aggregates Cellyan Biotechnology Co. Ltd's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow HKPD to receive live email and push alerts on every new disclosure.